The article focuses on the effects of merger and acquisition regulations introduced by the British Financial Services Authority on the commercial insurance industry in Great Britain. As a result of the regulations, companies seeking to acquire commercial insurance brokers will face a tough time to ...
Shops Your details *Email: *Confirm Email: Tel/Mobile: Your details: Verify Code: Submit
Office Your details *Email: *Confirm Email: Tel/Mobile: Your details: Verify Code: Submit
We are your partner in business insurance In our ever-changing world,business risksare constantly evolving. For more than 130 years, Allianz has been at the forefront, working closely with partners and customers to meet these challenges. At Allianz Commercial, we focus on providing businessesadvance...
Independent research firm Coleman Parkes surveyed 245 underwriters and 105 pricing actuaries across the UK and US working in Specialty and Commercial (re)insurance lines, on behalf of hyperexponential. The aim of the research was to identify the impact legacy technology and processes h...
We specialise in creating tailored corporate insurance and risk management programmes for large organisations across the UK and in over 150 countries.
Simple, flexible, and reliable commercial auto insurance for drivers in the US, UK, and the Netherlands. Discover INSHUR.
Insurance company underwriters are also active in setting up affinity schemes for UK commercial lines insurance. The report said that where it “was possible to identify scheme underwriters, including those involved in both brokered and directly underwritten programs, Hiscox emerged as the most prolific...
Faced with a lawsuit, for example, your company risks losing its assets—in the worst cases, it could spell the end of your venture. If you’re a sole proprietor, you could see lawyers come after your personal property, from money to real estate. Commercial insurance policies protect ...
This results in anupward migr... B Obika,R. Freer-hewish,D Newill - TRL - Crowthorne, UK 被引量: 7发表: 1992年 A randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor prognosis germ cell tumors (MRC TE23, CRUK 05/014, ISRC... 4508 ...